Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.16133
Abstract: The optimal infliximab dose intensification strategy to address secondary loss of response (LOR) remains unclear. This study aimed to compare clinical and pharmacokinetic outcomes following (i) upfront infliximab re‐induction with (ii) ongoing 6‐weekly dose interval… read more here.
Keywords: number doses; intensification strategy; response; dose intensification ... See more keywords